PIK3CD correlates with prognosis, epithelial-mesenchymal transition and tumor immune infiltration in breast carcinoma.

He W, Zhang H, Cheng H, Wen J, Li D

Open source

DOI
10.1007/s12672-023-00805-0
Published
2023 Oct 20
Container
Discover oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12672-023-00805-0,
  title = {PIK3CD correlates with prognosis, epithelial-mesenchymal transition and tumor immune infiltration in breast carcinoma.},
  author = {He W and Zhang H and Cheng H and Wen J and Li D},
  year = {2023},
  journal = {Discover oncology},
  doi = {10.1007/s12672-023-00805-0},
  url = {https://doi.org/10.1007/s12672-023-00805-0}
}

RIS

TY  - JOUR
TI  - PIK3CD correlates with prognosis, epithelial-mesenchymal transition and tumor immune infiltration in breast carcinoma.
AU  - He W
AU  - Zhang H
AU  - Cheng H
AU  - Wen J
AU  - Li D
PY  - 2023
JO  - Discover oncology
DO  - 10.1007/s12672-023-00805-0
UR  - https://doi.org/10.1007/s12672-023-00805-0
ER  - 

APA

W, H., H, Z., H, C., J, W., & D, L. (2023). PIK3CD correlates with prognosis, epithelial-mesenchymal transition and tumor immune infiltration in breast carcinoma.. Discover oncology. https://doi.org/10.1007/s12672-023-00805-0

Source records